Lixte Biotechnology Holdings- Warrants (01/01/2025) Accounts Payable

Lixte Biotechnology Holdings- Warrants (01/01/2025) (LIXTW) currently reports a accounts payable of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Lixte Biotechnology Holdings- Warrants (01/01/2025)'s accounts payable history and peer comparisons.

Lixte Biotechnology Holdings- Warrants (01/01/2025)'s accounts payable changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lixte Biotechnology Holdings- Warrants (01/01/2025) reported $0 in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lixte Biotechnology Holdings- Warrants (01/01/2025), and consider following LIXTW for alerts when major investors trade the stock.

Lixte Biotechnology Holdings- Warrants (01/01/2025) is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LIXTW with unrelated industries.